Kosan BioSciences -- KOSN | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Kosan BioSciences -- KOSN

An SI Board Since May 2001

Posts	SubjectMarks	Bans	Symbol
933	40	0	KOSN

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
908	tem 5.02. Departure of Directors or Certain Officers; Election of Directors; On	Icebrg	-	5/7/2008
907	[Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances t	tuck	-	5/7/2008
906	Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AA	mopgcw	-	4/16/2008
905	The old "if doesn't fly as a monotherapy or combo, there's always r	tuck	-	4/16/2008
904	Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Canc	mopgcw	-	4/14/2008
903	[Another Hsp90 inhibitor (and HDAC inhibitor), apparently from Schering AG, but	tuck	-	4/9/2008
902	<b>Resignation and Consulting Agreement with Robert G. Johnson, Jr., M.D.,	Icebrg	-	3/25/2008
901	Helen Kim has bought some shares too. Message 24420111	Icebrg	-	3/19/2008
900	Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs Mar	LJM	-	3/18/2008
899	Some insider buying. Message 24407158	Icebrg	-	3/16/2008
898	KOSN now at an all time low (I imagine) and selling for 12/31 cash on hand. That	rkrw	-	3/4/2008
897	Synta's is entirely synthetic as well.	rkrw	-	3/3/2008
896	Serenex is claiming greater potency than Conforma and Kosan versions. It also c	tuck	-	3/3/2008
895	It's all in the spelling - or the problem with biotech's; Kosan (KOSN)	Steve Lokness	-	3/3/2008
894	That or something seems to be countering a Needham Buy reiteration, this morning	tuck	-	3/3/2008
893	No price given. Press Release Source: Pfizer Inc Pfizer to Acquire Serenex	rkrw	-	3/3/2008
892	Actually, that's not right -- brain failure -- they are using entirely diffe	tuck	-	2/29/2008
891	>> as I don't think there's much differentiation in the underlying	scaram(o)uche	-	2/29/2008
890	>>Actually, I was serious. With composition of matter (from your notes of	tuck	-	2/29/2008
889	I can tell you the synta ceo has been talking up their hsp90 inhibitor as (throw	rkrw	-	2/29/2008
888	Actually, I was serious. With composition of matter (from your notes of the CC)	scaram(o)uche	-	2/29/2008
887	>>So you go to the people who have the formulation advantage, and partner	tuck	-	2/29/2008
886	>> at least that's the impression I have << So you go to the pe	scaram(o)uche	-	2/28/2008
885	Listened to most of it; Howard Liang from Leerink Swan basically asked my quest	tuck	-	2/28/2008
884	My questions re alvespimycin: Why is the IP protection stronger on the first ge	tuck	-	2/28/2008

Go to reply# or date (mm/dd/yy):